Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak

Manuel Jorge Rial; Marcela Valverde; Victoria Del Pozo; Francisco Javier González-Barcala; Carlos Martínez-Rivera; Xavier Muñoz; José María Olaguibel; Vicente Plaza; Elena Curto; Santiago Quirce; Pilar Barranco; Javier Domínguez-Ortega; Joaquin Mullol; César Picado; Antonio Valero; Irina Bobolea; Ebymar Arismendi; Paula Ribó; Joaquín Sastre

doi:10.1016/j.jaip.2020.09.050

Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak

J Allergy Clin Immunol Pract. 2021 Jan;9(1):487-489.e1. doi: 10.1016/j.jaip.2020.09.050. Epub 2020 Oct 9.

Authors

Manuel Jorge Rial¹, Marcela Valverde², Victoria Del Pozo³, Francisco Javier González-Barcala⁴, Carlos Martínez-Rivera⁵, Xavier Muñoz⁶, José María Olaguibel⁷, Vicente Plaza⁸, Elena Curto⁸, Santiago Quirce⁹, Pilar Barranco⁹, Javier Domínguez-Ortega⁹, Joaquin Mullol¹⁰, César Picado¹¹, Antonio Valero¹¹, Irina Bobolea¹¹, Ebymar Arismendi¹¹, Paula Ribó¹¹, Joaquín Sastre¹²

Affiliations

¹ Allergy Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain. Electronic address: manuterial@gmail.com.
² Allergy Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
³ Immunology Department, Instituto de Investigación, Sanitaria Hospital, Universitario Fundación Jiménez Díaz, Madrid, Spain; CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain.
⁴ CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain; Pneumology Department, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, La Coruña, Spain.
⁵ CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain; Pneumology Department, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain.
⁶ CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain; Departamento de Biología Celular, Fisiología e Inmunología, Universitat Autónoma de Barcelona, Barcelona, Spain; Pneumology Department, Hospital Vall d'Hebron, Barcelona, Spain.
⁷ CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain; Allergy Department, Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain.
⁸ CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain; Respiratory Medicine Department, Hospital de la Santa Creu i Sant Pau, Instituto de Investigación Biomédica Sant Pau (IIB Sant Pau), Universidad Autónoma de Barcelona, Departamento de Medicina, Barcelona, Spain.
⁹ CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain; Allergy Department, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.
¹⁰ CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain; Rhinology Unit & Smell Clinic, ENT Department, Barcelona, Spain; Clinical and Experimental Respiratory Immunoallergy (IDIBAPS), Barcelona, Spain; Universitat de Barcelona, Barcelona, Spain.
¹¹ CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain; Clinical and Experimental Respiratory Immunoallergy (IDIBAPS), Barcelona, Spain; Universitat de Barcelona, Barcelona, Spain; Allergy Unit & Severe Asthma Unit, Pneumonology and Allergy Department, Hospital Clínic, Barcelona, Spain.
¹² Allergy Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain; CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain.

No abstract available

Publication types

Multicenter Study

MeSH terms

Adult
Asthma / drug therapy*
Asthma / epidemiology*
Biological Products / therapeutic use*
COVID-19 / epidemiology*
Cohort Studies
Comorbidity
Disease Outbreaks
Female
Humans
Male
Middle Aged
Retrospective Studies
SARS-CoV-2
Severity of Illness Index
Spain / epidemiology

Substances

Biological Products